Aelis Farma SA (EPA:AELIS)
France · Delayed Price · Currency is EUR 1.190
+0.030 (2.59%)
Oct 16, 2025, 4:39 PM CET
Aelis Farma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Operating Revenue | 0.45 | 2.68 | 9.05 | 3.81 | 9.08 | - | Upgrade |
Other Revenue | 1.89 | 2.88 | 3.3 | 4.56 | 1.69 | 1.14 | Upgrade |
| 2.33 | 5.56 | 12.36 | 8.36 | 10.76 | 1.14 | Upgrade | |
Revenue Growth (YoY) | -78.36% | -54.99% | 47.75% | -22.28% | 846.53% | 12746.01% | Upgrade |
Gross Profit | 2.33 | 5.56 | 12.36 | 8.36 | 10.76 | 1.14 | Upgrade |
Selling, General & Admin | 3.02 | 3.36 | 2.61 | 3.1 | 1.34 | 0.66 | Upgrade |
Research & Development | 7.53 | 9.94 | 16.21 | 13.79 | 6.87 | 3.39 | Upgrade |
Other Operating Expenses | - | - | - | - | - | -0.07 | Upgrade |
Operating Expenses | 10.55 | 13.3 | 18.82 | 16.89 | 8.21 | 3.98 | Upgrade |
Operating Income | -8.22 | -7.74 | -6.46 | -8.53 | 2.55 | -2.84 | Upgrade |
Interest Expense | -0.25 | -0.23 | -0.16 | -0.11 | -0.14 | -0.14 | Upgrade |
Interest & Investment Income | 0.35 | 0.44 | 0.42 | 0.05 | 0 | 0 | Upgrade |
Currency Exchange Gain (Loss) | -0.09 | 0.05 | 1.09 | -0.01 | 0.72 | -0.02 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | 0.02 | 0.03 | -5.69 | -1.38 | -0.05 | Upgrade |
EBT Excluding Unusual Items | -8.19 | -7.45 | -5.08 | -14.29 | 1.76 | -3.04 | Upgrade |
Pretax Income | -8.18 | -7.45 | -5.08 | -14.29 | 1.76 | -3.04 | Upgrade |
Income Tax Expense | 0.01 | 0.01 | 0 | 0 | 1.19 | -0.96 | Upgrade |
Net Income | -8.2 | -7.46 | -5.08 | -14.29 | 0.57 | -2.09 | Upgrade |
Net Income to Common | -8.2 | -7.46 | -5.08 | -14.29 | 0.57 | -2.09 | Upgrade |
Shares Outstanding (Basic) | 14 | 13 | 13 | 12 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 14 | 13 | 13 | 12 | 10 | 10 | Upgrade |
Shares Change (YoY) | 3.44% | 4.22% | 8.94% | 23.49% | 0.01% | 7.72% | Upgrade |
EPS (Basic) | -0.60 | -0.55 | -0.39 | -1.21 | 0.06 | -0.22 | Upgrade |
EPS (Diluted) | -0.60 | -0.55 | -0.39 | -1.21 | 0.06 | -0.22 | Upgrade |
Free Cash Flow | -7.57 | -12.02 | -13.05 | -13.09 | 18.76 | -2.51 | Upgrade |
Free Cash Flow Per Share | -0.55 | -0.89 | -1.01 | -1.10 | 1.96 | -0.26 | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | -352.34% | -139.12% | -52.30% | -101.92% | 23.71% | -249.78% | Upgrade |
Profit Margin | -351.31% | -134.05% | -41.09% | -170.83% | 5.33% | -183.46% | Upgrade |
Free Cash Flow Margin | -324.39% | -216.13% | -105.58% | -156.48% | 174.29% | -221.02% | Upgrade |
EBITDA | -8.13 | -7.65 | -6.4 | -8.48 | 2.57 | -2.83 | Upgrade |
EBITDA Margin | - | -137.59% | -51.80% | -101.35% | 23.85% | -248.99% | Upgrade |
D&A For EBITDA | 0.09 | 0.09 | 0.06 | 0.05 | 0.02 | 0.01 | Upgrade |
EBIT | -8.22 | -7.74 | -6.46 | -8.53 | 2.55 | -2.84 | Upgrade |
EBIT Margin | - | -139.12% | -52.30% | -101.92% | 23.71% | -249.78% | Upgrade |
Effective Tax Rate | - | - | - | - | 67.37% | - | Upgrade |
Revenue as Reported | 2.33 | 5.56 | 12.36 | 8.36 | 10.76 | 1.14 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.